Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Raw Materials (2019 - 2022)

Historic Raw Materials for Marimed (MRMD) over the last 4 years, with Q1 2022 value amounting to $2.4 million.

  • Marimed's Raw Materials fell 3502.75% to $2.4 million in Q1 2022 from the same period last year, while for Mar 2022 it was $2.4 million, marking a year-over-year decrease of 3502.75%. This contributed to the annual value of $1.0 million for FY2021, which is 6972.34% down from last year.
  • Latest data reveals that Marimed reported Raw Materials of $2.4 million as of Q1 2022, which was down 3502.75% from $1.0 million recorded in Q4 2021.
  • Over the past 5 years, Marimed's Raw Materials peaked at $3.7 million during Q1 2021, and registered a low of $395167.0 during Q4 2019.
  • Moreover, its 4-year median value for Raw Materials was $2.4 million (2022), whereas its average is $2.3 million.
  • Per our database at Business Quant, Marimed's Raw Materials skyrocketed by 74835.65% in 2020 and then plummeted by 6972.34% in 2021.
  • Over the past 4 years, Marimed's Raw Materials (Quarter) stood at $395167.0 in 2019, then soared by 748.36% to $3.4 million in 2020, then tumbled by 69.72% to $1.0 million in 2021, then skyrocketed by 137.73% to $2.4 million in 2022.
  • Its Raw Materials stands at $2.4 million for Q1 2022, versus $1.0 million for Q4 2021 and $1.5 million for Q3 2021.